SFCM
UNCY icon

Seven Fleet Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Seven Fleet Capital Management’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
103,400
+47,700
+86% +$352K 0.09% 74
2026
Q1 		$367K Buy
+55,700
New +$365K 0.12% 92

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Seven Fleet Capital Management's UNCY Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Unicycive Therapeutics (UNCY) stake by 86% in Q2 2026, buying an estimated $352K and bringing the position to 103,400 shares worth $521K. The position accounts for 0.09% of the portfolio, ranked #74.

Seven Fleet Capital Management first reported a position in UNCY in Q1 2026 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Seven Fleet Capital Management held 103,400 shares of Unicycive Therapeutics worth $521K as of Q2 2026.
  • Seven Fleet Capital Management bought 47,700 Unicycive Therapeutics shares in Q2 2026, an estimated $352K.
  • Unicycive Therapeutics made up 0.09% of Seven Fleet Capital Management's portfolio in Q2 2026, its #74 holding.
  • Seven Fleet Capital Management first reported a position in Unicycive Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.